{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:32:18Z","timestamp":1774125138920,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s11926-005-0061-4","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:38:11Z","timestamp":1180784291000},"page":"99-105","source":"Crossref","is-referenced-by-count":43,"title":["Interstitial lung disease in polymyositis and dermatomyositis"],"prefix":"10.1007","volume":"7","author":[{"given":"Armin","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf gang Ludwig","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","volume":"55","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC: Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 1998, 55:1509\u20131512.","journal-title":"Arch Neurol"},{"key":"61_CR2","first-page":"1336","volume":"25","author":"I Marie","year":"1998","unstructured":"Marie I, Hatron PY, Hachulla E, et al.: Pulmonary involvement in polymyositis and in dermatomysitis. J Rheumatol 1998,25:1336\u20131343.A single center experience with various forms of lung involvement in PM\/DM is presented.","journal-title":"J Rheumatol"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.46.1.23","volume":"46","author":"S Lakhanpal","year":"1987","unstructured":"Lakhanpal S, Lie JT, Conn DL, et al.: Pulmonary disease in polymyositis\/ dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987, 46:23\u201329.","journal-title":"Ann Rheum Dis"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0049-0172(84)90010-6","volume":"14","author":"BF Dickey","year":"1984","unstructured":"Dickey BF, Myers AR: Pulmonary disease in polymyositis\/ dermatomyositis. Semin Arthritis Rheum 1984, 14:60\u201376.","journal-title":"Semin Arthritis Rheum"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0049-0172(88)90032-7","volume":"18","author":"EL Arsura","year":"1988","unstructured":"Arsura EL, Greenberg AS: Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988, 18:29\u201337.","journal-title":"Semin Arthritis Rheum"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Cherin P, et al.: Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002, 47:614\u2013622.Patients with interstitial lung disease were extracted from a large PM\/DM cohort and examined for pulmonary findings and extrapulmonary disease. Predictors of the long-term course are described and the UIP pattern on biopsy was linked to a poor response to immunosuppression.","journal-title":"Arthritis Rheum"},{"key":"61_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","volume":"28","author":"J Banbassat","year":"1985","unstructured":"Banbassat J, Gelfel D, Larholt K, et al.: Prognostic factors in polymyositis\/dermatomyositis: a computer-assisted analysis in 92 cases. Arthritis Rheum 1985, 28:249\u2013255.","journal-title":"Arthritis Rheum"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","volume":"14","author":"TA Medsger","year":"1971","unstructured":"Medsger TA, Robinson H, Masi AT: Factors affecting survivorship in polymyositis: a life table study of 124 patients. Arthritis Rheum 1971, 14:249\u2013258.","journal-title":"Arthritis Rheum"},{"key":"61_CR9","first-page":"1186","volume":"23","author":"A Kadoya","year":"1996","unstructured":"Kadoya A, Okada J, Iikuni Y, Kondo H: Risk factors for pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996, 23:1186\u20131188.","journal-title":"J Rheumatol"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9149(78)90871-8","volume":"41","author":"JS Gottdiener","year":"1978","unstructured":"Gottdiener JS, Sherber HS, Hawley RJ, et al.: Cardiac manifestations of polymyositis. Am J Cardiol 1978, 41:1141\u20131149.","journal-title":"Am J Cardiol"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","volume":"22","author":"CE Denvow","year":"1979","unstructured":"Denvow CE, Lie JT, Tancredi RJ, et al.: Cardiac involvement in polymyositis. Arthritis Rheum 1979, 22:1088\u20131092.","journal-title":"Arthritis Rheum"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW: Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990, 33:1361\u20131370.","journal-title":"Arthritis Rheum"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao AH, Lacomis D, Lucas M, et al.: Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004, 50:209\u2013215.","journal-title":"Arthritis Rheum"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1378\/chest.79.1.105","volume":"79","author":"TW Bunch","year":"1981","unstructured":"Bunch TW, Tancredi RC, Lie JT: Pulmonary hypertension in polymyositis. Chest 1981, 79:105\u2013107.","journal-title":"Chest"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1378\/chest.98.2.352","volume":"98","author":"CA Hebert","year":"1990","unstructured":"Hebert CA, Byrnes TJ, Baethge BA, et al.: Exercise limitation in patients with polymyositis. Chest 1990, 98:352\u2013357.","journal-title":"Chest"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9343(78)90455-2","volume":"64","author":"RH Young","year":"1978","unstructured":"Young RH, Mark GJ: Pulmonary vascular changes in scleroderma. Am J Med 1978, 64:998\u20131004.","journal-title":"Am J Med"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","volume":"48","author":"V Steen","year":"2003","unstructured":"Steen V, Medsger TA: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516\u2013522.","journal-title":"Arthritis Rheum"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","volume":"32","author":"A Schnabel","year":"2003","unstructured":"Schnabel A, Reuter M, Biederer J, etal.: Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003, 32:273\u2013284.Patients with PM\/DM lung disease were identified by standardized screening and stratified according to the presence or absence of functional deterioration. Intravenous pulse cyclophosphamide was universally effective at halting pulmonary deterioration in the patients with progressive disease.","journal-title":"Semin Arthritis Rheum"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","volume":"63","author":"M Fathi","year":"2004","unstructured":"Fathi M, Dastmalchi M, Rasmussen E, et al.: Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004, 63:297\u2013301.","journal-title":"Ann Rheum Dis"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, etal.: Polymyositisdermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001, 164:1182\u20131185.Clinical characteristics and survival were examined retrospectively in a large cohort of patients with PM\/DM lung disease. NSIP was the most prevalent histopathological pattern in the patients undergoing lung biopsy and survival of the entire cohort was similar to that reported in idiopathic NSIP.","journal-title":"Am J Respir Crit Care Med"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","volume":"44","author":"D Tansey","year":"2004","unstructured":"Tansey D, Wells AU, Colby TV, et al.: Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004, 44:585\u2013596.Lung biopsies from patients with various forms of connective tissue diseases were categorized histopathologically according to the 2000 American Thoracic Society\/European Respiratory Society consensus statement. NSIP with or without accompanying organizing pneumonia was the most common histopathology in PM\/DM lung disease.","journal-title":"Histopathology"},{"key":"61_CR22","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society international multidisciplinary concsensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277\u2013304.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","volume":"157","author":"JA Bjoraker","year":"1998","unstructured":"Bjoraker JA, Ryu JH, Edwin MK, et al.: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199\u2013203.","journal-title":"Am J Respir Crit Care Med"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/ajrccm\/141.3.727","volume":"141","author":"HD Tazelaar","year":"1990","unstructured":"Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV: Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990, 141:727\u2013733.","journal-title":"Am Rev Respir Dis"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00296-001-0146-y","volume":"21","author":"I Yamadori","year":"2001","unstructured":"Yamadori I, Fujita J, Kajitani H, et al.: Lymphocyte subsets in lung tissues of interstitial pneumonia associated with untreated polymyositis\/dermatomyositis. Rheumatol Int 2001,21:89\u201393.","journal-title":"Rheumatol Int"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al.: Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003, 22:245\u2013250.","journal-title":"Eur Respir J"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1183\/09031936.97.10122907","volume":"10","author":"A Sauty","year":"1997","unstructured":"SautyA, RochatT, Schoch OD, etal.: Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997, 10:2907\u20132912.","journal-title":"Eur Respir J"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1440-1843.1999.00179.x","volume":"4","author":"K Kourakata","year":"1999","unstructured":"Kourakata K, Takada T, Suzuki E, et al.: Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis\/dermatomyositis with interstitial pneumonia. Respirology 1999, 4:223\u2013228.","journal-title":"Respirology"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0720-048X(03)00094-9","volume":"49","author":"O Bonnefoy","year":"2004","unstructured":"Bonnefoy O, Ferretti G, Calaque O, et al.: Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol 2004, 49:235\u2013244.","journal-title":"Eur J Radiol"},{"key":"61_CR30","first-page":"1921","volume":"23","author":"JM Grau","year":"1996","unstructured":"Grau JM, Miro O, Pedrol E, et al.: Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996, 23:1921\u20131926.","journal-title":"J Rheumatol"},{"key":"61_CR31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.123.4.1096","volume":"123","author":"H Arakawa","year":"2003","unstructured":"Arakawa H, Yamada H, Kurihara Y, et al.: Nonspecific interstitial pneumonia associated with polymyostis and dermatomyositis. Serial high-resolution CT-findings and functional correlation. Chest 2003, 123:1096\u20131103.","journal-title":"Chest"},{"key":"61_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/ajr.169.1.9207505","volume":"169","author":"M Mino","year":"1997","unstructured":"Mino M, Noma S, Tagushi Y, et al.: Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 1997, 169:83\u201387.","journal-title":"AJR Am J Roentgenol"},{"key":"61_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.210.2.r99ja15333","volume":"210","author":"M Akira","year":"1999","unstructured":"Akira M, Hara H, Sakatani M: Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 1999, 210:333\u2013338.","journal-title":"Radiology"},{"key":"61_CR34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","volume":"11","author":"J Ikezoe","year":"1996","unstructured":"Ikezoe J, Johkoh T, Kohno N, et al.: High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thoracic Imaging 1996, 11:250\u2013259.","journal-title":"J Thoracic Imaging"},{"key":"61_CR35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002281-200101000-00003","volume":"13","author":"U Specks","year":"2001","unstructured":"Specks U: Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001, 13:12\u201317.","journal-title":"Curr Opin Rheumatol"},{"key":"61_CR36","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1164\/ajrccm.151.6.7767555","volume":"151","author":"MI Schwarz","year":"1995","unstructured":"Schwarz MI, Sutarik JM, Nick JA, et al.: Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med 1995, 151:2037\u20132040.","journal-title":"Am J Respir Crit Care Med"},{"key":"61_CR37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","volume":"77","author":"C Marguerie","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HLC, et al.: Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Medicine 1990, 77:1019\u20131038.","journal-title":"Q J Medicine"},{"key":"61_CR38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC: Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996, 26:459\u2013467.","journal-title":"Semin Arthritis Rheum"},{"key":"61_CR39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/art.1780350718","volume":"35","author":"IN Targoff","year":"1992","unstructured":"Targoff IN, Trieu EP, Plotz PH, Miller FW: Antibodies to glycyl transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992, 35:821\u2013830.","journal-title":"Arthritis Rheum"},{"key":"61_CR40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Hengstman GJD, Egberts WV, et al.: Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116\u2013123.","journal-title":"Ann Rheum Dis"},{"key":"61_CR41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.289.6438.151","volume":"289","author":"RM Bernstein","year":"1984","unstructured":"Bernstein RM, Morgan SH, Chapman J, et al.: Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J 1984, 289:151\u2013152.","journal-title":"Br Med J"},{"key":"61_CR42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9629(15)40734-7","volume":"319","author":"MJ Garlepp","year":"2000","unstructured":"Garlepp MJ, Mastaglia FL: Autoantibodies in inflammatory myophaties. Am J Med Sci 2000, 319:227\u2013233.","journal-title":"Am J Med Sci"},{"key":"61_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00005792-198407000-00004","volume":"63","author":"M Peters-Golden","year":"1984","unstructured":"Peters-Golden M, Wise RA, Schneider P, et al.: Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine 1984, 63:221\u2013231.","journal-title":"Medicine"},{"key":"61_CR44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ard.59.9.709","volume":"59","author":"BKS Davidson","year":"2000","unstructured":"Davidson BKS, Kelly CA, Griffith ID: Ten year follow up of pulmonary function in patients with primary Sjoegrens syndrome. Ann Rheum Dis 2000, 59:709\u2013712.","journal-title":"Ann Rheum Dis"},{"key":"61_CR45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y","volume":"41","author":"A Schnabel","year":"1998","unstructured":"Schnabel A, Reuter M, Gross WL: Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998, 41:1215\u20131220.","journal-title":"Arthritis Rheum"},{"key":"61_CR46","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","volume":"353","author":"CV Oddis","year":"1999","unstructured":"Oddis CV, Sciurba FC, Abu Elmagd K, Starzl TE: Tacrolimus in refractory interstitial lung disease. Lancet 1999, 353:1762\u20131763.","journal-title":"Lancet"},{"key":"61_CR47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.1780370904","volume":"37","author":"VD Steen","year":"1994","unstructured":"Steen VD, Lanz JK, Conte Cowens GR, Medsger TA: Therapy for severe interstitial lung disease in systemic sclerosis. Arthritis Rheum 1994, 37:1290\u20131296.","journal-title":"Arthritis Rheum"},{"key":"61_CR48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","volume":"132","author":"B White","year":"2000","unstructured":"White B, Moore WC, Wigley FM, et al.: Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000, 132:947\u2013954.","journal-title":"Ann Intern Med"},{"key":"61_CR49","first-page":"1527","volume":"26","author":"Y Nawata","year":"1999","unstructured":"Nawata Y, Kurasawa K, Takabayashi K, et al.: Corticosteroid resistant interstitial pneumonitis in polymyositis\/dermatomyositis: prediction and treatment with cyclosporine. J Rheumatol 1999, 26:1527\u20131533.","journal-title":"J Rheumatol"},{"key":"61_CR50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03009749709065660","volume":"26","author":"K Maeda","year":"1997","unstructured":"Maeda K, Kimura R, Komuta K, Igarashi T: cyclosporine treatment for polymyositis\/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 1997, 26:24\u201329.","journal-title":"Scand J Rheumatol"},{"key":"61_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005792-197601000-00005","volume":"55","author":"MI Schwarz","year":"1976","unstructured":"Schwarz MI, Matthay RA, Sahn SA, et al.: Interstitial lung disease in polymyositis and dermatomyositis: analysis of 6 cases and review of the literature. Medicine 1976, 55:89\u2013104.","journal-title":"Medicine"},{"key":"61_CR52","first-page":"877","volume":"20","author":"YT Hsue","year":"1993","unstructured":"Hsue YT, Paulus HE, Coulson WF: Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival. J Rheumatol 1993, 20:877\u2013879.","journal-title":"J Rheumatol"},{"key":"61_CR53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2169\/internalmedicine.36.519","volume":"36","author":"T Shinohara","year":"1997","unstructured":"Shinohara T, Hidaka T, Matsuki Y, et al.: Rapidly progressive lung disease associated with dermatomyositis responding to intravenous pulse cyclophosphamide pulse therapy. Int Med 1997, 36:519\u2013523.","journal-title":"Int Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-005-0061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-005-0061-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-005-0061-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:47:17Z","timestamp":1559422037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-005-0061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11926-005-0061-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}